CorMedix, Inc. (CRMD)
7.845
-0.06
(-0.82%)
USD |
NASDAQ |
May 19, 14:54
CorMedix Market Cap : 615.46M for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 146.13B |
| Eli Lilly & Co. | 905.77B |
| Theravance Biopharma, Inc. | 832.58M |
| Hyperion DeFi, Inc. | 39.19M |
| Corcept Therapeutics, Inc. | 6.181B |
Market Cap Related Metrics
| PE Ratio | 3.737 |
| PS Ratio | 1.691 |
| PEG Ratio | 0.0045 |
| Price to Book Value | 1.408 |
| Price to Free Cash Flow | 3.475 |
| Price | 7.845 |
| Earnings Yield | 26.76% |
| PEGY Ratio | 0.0045 |
| Operating PE Ratio | 3.494 |
| Normalized PE Ratio | 3.622 |